New Therapeutic Approaches to the Treatment of Dyslipidemia 2: LDL-C and Lp(a)
Dyslipidemia is an important risk factor for atherosclerotic cardiovascular disease (ASCVD). There are abundant and unequivocal data to indicate that low-density lipoproteins (LDL) are a cause of ASCVD. Reduction of plasma low-density lipoprotein cholesterol (LDL-C) by medical therapy such as statin...
Gardado en:
| Principais autores: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
The Korean Society of Lipid and Atherosclerosis
2023-01-01
|
| Series: | Journal of Lipid and Atherosclerosis |
| Assuntos: | |
| Acceso en liña: | https://www.e-jla.org/search.php?where=aview&id=10.12997/jla.2023.12.1.37&code=9992JLA&vmode=FULL |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|